Biotron Ltd BITRF:OTCPK

RT Quote | Exchange | USD
Last | 01/13/22 EST
0.0578UNCH (UNCH)
52 week range
0.02 - 0.09
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0578
  • 52 Week High0.09
  • 52 Week High Date01/28/21
  • 52 Week Low0.02
  • 52 Week Low Date11/17/21

Key Stats

  • Market Cap44.19M
  • Shares Out701.93M
  • 10 Day Average Volume2,409
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.93

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0578
  • 52 Week High0.09
  • 52 Week High Date01/28/21
  • 52 Week Low0.02
  • 52 Week Low Date11/17/21
  • Market Cap44.19M
  • Shares Out701.93M
  • 10 Day Average Volume2,409
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-16.95
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biotron Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biotron Limited is a biotechnology company. The Company is engaged in the funding and management of intermediate, and applied biotechnology research and development projects. It is engaged in developing small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and human immunodeficiency virus-1 (HIV-1). The Company's lead drug, BIT225 is in Phase II clinical development for the treatment of HIV-1 and HCV infections. BIT225 is a...
Michael Hoy
Independent Non-Executive Chairman of the Board
Michelle Miller Ph.D.
Chief Executive Officer, Managing Director, Executive Director
Address
Suite 3.3, 56 Delhi Road
North Ryde, NSW
2113
Australia